I took Monty for his annual check up last week. He's had some significant deterioration with his HD and Ed, with the osteoarthritis in his other joints getting a little worse. We also had his annual blood test done, and it showed higher levels (through still just within normal range) of creatine and urea, suggesting a possible kidney issue, not a complete surprise as he's been on a daily dose (60-100% as needed) of meloxicam for 6+ years We are taking in a urine sample this Friday when he goes for hydro.
The vet suggested he would be a good candidate for a new drug, Librela. I'm struggling to find much about it so far, it seems really new, this is from Zoetis:
ZAVENTEM, Belgium--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Librela (bedinvetmab), the first injectable monoclonal antibody (mAb) therapy approved in the European Union for monthly alleviation of osteoarthritis (OA) pain in dogs. Librela provides veterinarians a new treatment option, which effectively controls OA pain for a month, while also offering a positive safety profile.
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain1 and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact.After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.
The benefits of this, and may particularly useful in Monty's case, would be that you can discontinue the NSAIDs and potentially just have this monthly injection as an alternative painkiller.
Has anyone heard of this new drug, or know anyone who has tried it?
news.zoetis.com
www.vettimes.co.uk
The vet suggested he would be a good candidate for a new drug, Librela. I'm struggling to find much about it so far, it seems really new, this is from Zoetis:
ZAVENTEM, Belgium--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Librela (bedinvetmab), the first injectable monoclonal antibody (mAb) therapy approved in the European Union for monthly alleviation of osteoarthritis (OA) pain in dogs. Librela provides veterinarians a new treatment option, which effectively controls OA pain for a month, while also offering a positive safety profile.
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain1 and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact.After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.
The benefits of this, and may particularly useful in Monty's case, would be that you can discontinue the NSAIDs and potentially just have this monthly injection as an alternative painkiller.
Has anyone heard of this new drug, or know anyone who has tried it?
Zoetis Receives European Commission Marketing Authorization for Librela® (bedinvetmab)
The first injectable monoclonal antibody authorized for alleviation of osteoarthritis pain in dogs Librela works differently from other pain medications, combining one month of pain control and increased mobility, with a proven safety and efficacy profile Librela has a unique mode of action...
Vet Times: Latest Veterinary News, Jobs & Clinical Resources
Stay ahead in veterinary medicine with Vet Times. Get the latest news, expert clinical insights, and top job opportunities for vets and nurses.